Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minmin Yao

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Senolytic therapy preserves blood-brain barrier integrity and promotes microglia homeostasis in a tauopathy modelMinmin Yao, Zhiliang Wei, JOnathan S Nielsen, et al.
Drug Design, Development and Therapy|December 20, 2014
Matrix-induced autologous chondrocyte implantation for the treatment of chondral defects of the knees in Chinese patientsZhongwen Zhang, Xin Zhong, Huiru Ji, et al.
Neurobiology of Disease|October 22, 2024
Senolytic therapy preserves blood-brain barrier integrity and promotes microglia homeostasis in a tauopathy modelMinmin Yao, Zhiliang Wei, Jonathan Scharff Nielsen, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Progressively reduced cerebral oxygen metabolism and elevated plasma NfL levels in the zQ175DN mouse model of Huntington's diseaseQian Wu, Minmin Yao, Hongshuai Liu, et al.
Experimental Neurology|September 13, 2025
Progressively reduced cerebral oxygen metabolism and elevated plasma NfL levels in the zQ175DN mouse model of Huntington's diseaseQian Wu, Minmin Yao, Hongshuai Liu, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2025
Cell type-specific contributions to impaired blood-brain barrier and cerebral metabolism in presymptomatic 5XFAD miceMinmin Yao, Na Sun, Raleigh Linville, et al.
Fluids and Barriers of the CNS|January 8, 2026
Neurovascular and metabolic dysfunction with cell type-specific transcriptomic changes in presymptomatic 5XFAD miceMinmin Yao, Na Sun, Raleigh Linville, et al.
Nature Neuroscience|December 12, 2022
An RNA-targeting CRISPR-Cas13d system alleviates disease-related phenotypes in Huntington's disease modelsKathryn H Morelli, Qian Wu, Maya L Gosztyla, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Senolytic therapy preserves blood-brain barrier integrity and promotes microglia homeostasis in a tauopathy modelMinmin Yao, Zhiliang Wei, JOnathan S Nielsen, et al.
Drug Design, Development and Therapy|December 20, 2014
Matrix-induced autologous chondrocyte implantation for the treatment of chondral defects of the knees in Chinese patientsZhongwen Zhang, Xin Zhong, Huiru Ji, et al.
Neurobiology of Disease|October 22, 2024
Senolytic therapy preserves blood-brain barrier integrity and promotes microglia homeostasis in a tauopathy modelMinmin Yao, Zhiliang Wei, Jonathan Scharff Nielsen, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Progressively reduced cerebral oxygen metabolism and elevated plasma NfL levels in the zQ175DN mouse model of Huntington's diseaseQian Wu, Minmin Yao, Hongshuai Liu, et al.
Experimental Neurology|September 13, 2025
Progressively reduced cerebral oxygen metabolism and elevated plasma NfL levels in the zQ175DN mouse model of Huntington's diseaseQian Wu, Minmin Yao, Hongshuai Liu, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2025
Cell type-specific contributions to impaired blood-brain barrier and cerebral metabolism in presymptomatic 5XFAD miceMinmin Yao, Na Sun, Raleigh Linville, et al.
Fluids and Barriers of the CNS|January 8, 2026
Neurovascular and metabolic dysfunction with cell type-specific transcriptomic changes in presymptomatic 5XFAD miceMinmin Yao, Na Sun, Raleigh Linville, et al.
Nature Neuroscience|December 12, 2022
An RNA-targeting CRISPR-Cas13d system alleviates disease-related phenotypes in Huntington's disease modelsKathryn H Morelli, Qian Wu, Maya L Gosztyla, et al.
Pageof 3